17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Richard Lummis and I are back to continue our series of exploring leadership through the study of US...
Read More >
On August 20, 2019, the U.S. Department of Labor’s Occupational Safety and Health Administration (“...
Read More >
Right of First Refusal EO Revoked. Last week, President Trump issued an Executive Order revoking Exe...
Read More >
The U.S. Supreme Court has agreed to review two consolidated cases that will afford it an opportunit...
Read More >
In DLO Enterprises, Inc. v. Innovative Chemical Products Group, LLC, the Delaware Court of Chancery ...
Read More >
The viral outbreak that exploded out of central China suddenly has captured the rapt attention of Wa...
Read More >